Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;14(1):52-60.
doi: 10.1111/ajco.12818. Epub 2017 Oct 30.

Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers

Allan 'Ben' Smith  1   2 , Meera Agar  1   3   4 , Geoff Delaney  1   2   4 , Joseph Descallar  1   2 , Kelsey Dobell-Brown  3   4 , Melissa Grand  3   4 , Jennifer Aung  3   4 , Pinky Patel  3   4 , Nasreen Kaadan  1   4 , Afaf Girgis  1   2
Affiliations

Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers

Allan 'Ben' Smith et al. Asia Pac J Clin Oncol. 2018 Feb.

Abstract

Aim: Clinical trials play a critical role in advancing cancer care, but international research shows that few cancer patients, particularly culturally and linguistically diverse (CALD) patients, participate in trials. This limits generalizability of trial results and increases health disparities. This study aimed to establish rates and correlates of trial participation among CALD patients in South Western Sydney Local Health District (SWSLHD), a highly culturally diverse area.

Methods: Data from all cancer patients diagnosed and/or treated in SWSLHD from January 2006 to July 2016 were analyzed retrospectively. The primary outcome was trial enrolment among patients born in non-English speaking countries (CALD) versus English speaking countries (non-CALD). Multivariable logistic regression evaluated CALD status as a predictor of trial participation. Moderators of trial participation by the different CALD groups, namely those whose preferred language was English (CALD-PLE) or was not English (CALD-PLNE), were examined by testing interactions between CALD status and other demographic and clinical variables.

Results: A total of 19 453 patients were analyzed (54.9% non-CALD, 16.5% CALD-PLE, 18.5% CALD-PLNE). Overall, 7.4% of patients were enrolled in a trial. Trial participation was significantly lower in CALD patients than non-CALD patients (5.7% vs 8.4%; odds ratio [OR] = 0.80; 95% confidence interval [CI], 0.69-0.91; P = 0.001). CALD-PLNE patients were less likely to participate in trials than non-CALD (OR = 0.45; 95% CI, 0.36-0.56; P < 0.0001) and CALD-PLE patients (OR = 0.53; 95% CI, 0.67-0.41; P < 0.0001).

Conclusions: Limited English proficiency seems particularly unfavorable to trial participation. Development and evaluation of strategies to overcome language barriers (e.g. simplified and translated multimedia participant information materials) is needed.

Keywords: cancer; clinical trials; culturally and linguistically diverse; migrants.

PubMed Disclaimer

Comment in

LinkOut - more resources